Novavax's stock was trading down more than 6% Tuesday afternoon after the company lowered its guidance for sales for the year ...

Kennedy’s role is expected to be far-reaching and extend into reshaping how vaccines are regulated, since he has emerged in ...

Gilead Sciences ( GILD) increased its growth forecast for the year on strong third quarter results, marking a shift away from ...

Introduction, Overview, and in-depth industry analysis are all included in the 2024 updated report. . The COVID-19 Pandemic Outbreak Impact Analysis ... The report offers a deep analysis of the key ...

Just as in the wake of COVID-19, the world will look to pharma ... any disruption to the production or distribution of pharmaceutical products can have significant cost implications for the ...

But in the wake of the COVID-19 pandemic, there is an even greater ... The launch environment for pharmaceutical industry products is evolving at pace with new scientific discoveries and shifting ...

Talks between WHO member states on a landmark global accord on handling future pandemics will roll into 2025 after countries ...

Analysis time of SR-DLS is considerably shorter compared to conventional DLS. A SR-DLS measurement takes less than 10 seconds ...

In March 2020, Bioavanta-Bosti, a renowned researcher in chitosan nanoparticles, introduced Novochizol. This innovative ...

“Research on the potential health benefits of medical-grade manuka honey is ongoing, and increasing attention is being ...

Q3 2024 Earnings Conference Call November 7, 2024 11:00 AM ETCompany ParticipantsKim Golodetz - Alliance Advisors ...

Aptevo Therapeutics and Alligator Bioscience report favorable safety, tolerability and evidence of biological activity of ALG.APV-527, more than half of evaluable patients achieved stable diseaseColon ...